Imunon, Inc.

IMNN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000749647

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 6 sells

Sold $38.13K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

23

+4 vs. Q1 2026
Total value $753.83K

View 13F holders

Superinvestors holding IMNN

0

None of the superinvestors held IMNN at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by IMNN insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Sep 1, 20264:06 PM ET	Aug 31, 2026	Eylward SusanGeneral Counsel and Corp Sec	SSaleCommon Stock	−2.53K	$1.5643	−$3.95K	2.9K	−46.6%	SEC
Aug 17, 20264:17 PM ET	Aug 17, 2026	Eylward SusanGeneral Counsel and Corp Sec	SSaleCommon Stock	−2.45K	$1.6303	−$3.99K	2.9K	−45.8%	SEC
Aug 4, 20264:13 PM ET	Aug 3, 2026	Eylward SusanGeneral Counsel and Corp Sec	SSaleCommon Stock	−2.54K	$1.5651	−$3.98K	2.9K	−46.7%	SEC
Jul 21, 20264:15 PM ET	Jul 20, 2026	Eylward SusanGeneral Counsel and Corp Sec	SSaleCommon Stock	−2.15K	$1.7816	−$3.83K	2.9K	−42.6%	SEC
Jul 7, 20264:58 PM ET	Jul 6, 2026	Eylward SusanGeneral Counsel and Corp Sec	SSaleCommon Stock	−920	$1.88	−$1.73K	2.9K	−24.1%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in IMNN at the end of Q2 2026.

Institutions holding IMNN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
ARMISTICE CAPITAL, LLC	144,767	$257.69K	0.01%	−203,563−58.4%	Reduced
Riverview Capital Advisers, LLC	34,364	$247.77K	0.07%	00.0%	Unchanged
VANGUARD CAPITAL MANAGEMENT LLC	46,967	$83.6K	0.00%	−1,089−2.3%	Reduced
GEODE CAPITAL MANAGEMENT, LLC	31,629	$56.3K	0.00%	−1,582−4.8%	Reduced
Virtu Financial LLC	17,456	$31K	0.00%	+17,456	New